|
Somatic mutations identify a sub-group of aplastic anemia patients that progress to myelodysplastic syndrome
|
Aug 2014
|
Blood
|
aplastic anemia
|
|
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.
|
Aug 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
How we treat higher-risk myelodysplastic syndromes
|
Dec 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Clonal hematopoiesis in acquired aplastic anemia
|
Apr 2016
|
Blood
|
aplastic anemia
|
|
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
|
Jan 2019
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
How I Treat Paroxysmal nocturnal hemoglobinuria
|
Jan 2021
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Reduced ribosomal RNA expression and increased ribosomal DNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes
|
Oct 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution
|
Apr 2019
|
Blood
|
aplastic anemia
|
|
How we treat lower risk myelodysplastic syndromes.
|
Apr 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Stem and progenitor cell alterations in myelodysplastic syndromes
|
Feb 2017
|
Blood
|
myelodysplastic syndromes (MDS)
|
